1. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
   Zaynab Shakkour et al, 2021, Current Medicinal Chemistry CrossRef
2. Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
   Liaisan Arslanbaeva et al, 2022, Molecules CrossRef
3. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
   Yao Xiang et al, 2024, Archives of Toxicology CrossRef
4. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
   Teresa Cunha-Oliveira et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
5. Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
   Jiping Li et al, 2021, Frontiers in Pharmacology CrossRef
6. A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
   Sarmistha Saha et al, 2022, Frontiers in Cellular Neuroscience CrossRef
7. Repurposing of Various Current Medicines as Radioprotective Agents
   Rajwinder Kaur et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
8. Enhancing the Neuroprotection Potential of Edaravone in Transient Global Ischemia Treatment with Glutathione- (GSH-) Conjugated Poly(methacrylic acid) Nanogel as a Promising Carrier for Targeted Brain Drug Delivery
   Faezeh Mozafari et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
9. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
   Emilia Zgorzynska et al, 2021, International Journal of Molecular Sciences CrossRef
10. Edaravone in the treatment of concussion and post-concussion syndrome
    O.A. Halushko, 2023, Infusion & Chemotherapy CrossRef
11. An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study
    Shotaro Haji et al, 2023, JMIR Research Protocols CrossRef
12. Edaravone Attenuates Disease Severity of Experimental Auto-Immune Encephalomyelitis and Increases Gene Expression of Nrf2 and HO-1
    D MICHALIČKOVÁ et al, 2022, Physiological Research CrossRef
13. Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone
    Helene Ismail et al, 2020, Antioxidants CrossRef
14. Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR‐4/NF‐κB, and JAK1/STAT3 signaling in cyclophosphamide‐intoxicated rats
    Emad H. M. Hassanein et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
15. Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
    Peng Ren et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
16. The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing
    Aki Soejima-Kusunoki et al, 2022, Pharmaceuticals CrossRef
17. Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells
    Diana Duarte et al, 2022, Current Issues in Molecular Biology CrossRef
18. NIR-II Dyad-Doped Ratiometric Nanosensor with Enhanced Spectral Fidelity in Biological Media for In Vivo Biosensing
    Peng Yu et al, 2022, Nano Letters CrossRef
19. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury
    Zaynab Shakkour et al, 2021, The Neuroscientist CrossRef
20. Auricular Electroacupuncture for Late Posttraumatic Epilepsy after Severe Brain Injury: A Retrospective Study
    Cui-Cui Shen et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
21. Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
    Daniela Baracaldo-Santamaría et al, 2022, Pharmaceutics CrossRef
22. Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2
    Wen Zhang et al, 2022, BioMed Research International CrossRef
23. Docetaxel-induced cognitive impairment in rats can be ameliorated by edaravone dexborneol: Evidence from the indicators of biological behavior and anisotropic fraction
    Ping Liu et al, 2023, Frontiers in Neuroscience CrossRef